Somatostatin mediates its diverse physiological effects through a family of five G-protein-coupled receptors (sst 1 -sst 5 ); however, knowledge about the distribution of individual somatostatin receptor proteins in mammalian brain is incomplete. In the present study, we have examined the regional and subcellular distribution of the somatostatin receptor sst 4 in the rat CNS by raising anti-peptide antisera to the C-terminal tail of sst 4 . The specificity of affinity-purified antibodies was demonstrated using immunofluorescent staining of HEK 293 cells stably transfected with an epitope-tagged sst 4 receptor. In Western blotting, the antiserum reacted specifically with a broad band in rat brain, which migrated at ϳ70 kDa before and ϳ50 kDa after enzymatic deglycosylation. sst 4 -Like immunoreactivity was most prominent in many forebrain regions, including the cerebral cortex, hippocampus, striatum, amygdala, and hypothalamus. Analysis at the electron microscopic level revealed that sst 4 -expressing neurons target this receptor preferentially to their somatodendritic domain. Like the sst 2A receptor, sst 4 -immunoreactive dendrites were often closely apposed by somatostatin-14-containing fibers and terminals. However, unlike the sst 2A receptor, sst 4 was not internalized in response to intracerebroventricular administration of somatostatin-14. After percussion trauma of the cortex, neuronal sst 4 receptors progressively declined at the sites of damage. This decline coincided with an induction of sst 4 expression in cells with a glial-like morphology. Together, this study provides the first description of the distribution of immunoreactive sst 4 receptor proteins in rat brain. We show that sst 4 is strictly somatodendritic and most likely functions in a postsynaptic manner. In addition, the sst 4 receptor may have a previously unappreciated function during the neuronal degeneration-regeneration process.
Somatostatin mediates its diverse physiological effects through a family of five G-protein-coupled receptors (sst 1 -sst 5 ); however, knowledge about the distribution of individual somatostatin receptor proteins in mammalian brain is incomplete. In the present study, we have examined the regional and subcellular distribution of the somatostatin receptor sst 4 in the rat CNS by raising anti-peptide antisera to the C-terminal tail of sst 4 . The specificity of affinity-purified antibodies was demonstrated using immunofluorescent staining of HEK 293 cells stably transfected with an epitope-tagged sst 4 receptor. In Western blotting, the antiserum reacted specifically with a broad band in rat brain, which migrated at ϳ70 kDa before and ϳ50 kDa after enzymatic deglycosylation. sst 4 -Like immunoreactivity was most prominent in many forebrain regions, including the cerebral cortex, hippocampus, striatum, amygdala, and hypothalamus. Analysis at the electron microscopic level revealed that sst 4 -expressing neurons target this receptor preferentially to their somatodendritic domain. Like the sst 2A receptor, sst 4 -immunoreactive dendrites were often closely apposed by somatostatin-14-containing fibers and terminals. However, unlike the sst 2A receptor, sst 4 was not internalized in response to intracerebroventricular administration of somatostatin-14. After percussion trauma of the cortex, neuronal sst 4 receptors progressively declined at the sites of damage. This decline coincided with an induction of sst 4 expression in cells with a glial-like morphology. Together, this study provides the first description of the distribution of immunoreactive sst 4 receptor proteins in rat brain. We show that sst 4 is strictly somatodendritic and most likely functions in a postsynaptic manner. In addition, the sst 4 receptor may have a previously unappreciated function during the neuronal degeneration-regeneration process.
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The neuropeptide somatostatin exerts a variety of effects in the CNS and peripheral nervous system. Two biological active forms have been identified in mammals, the cyclic tetradecapeptide somatostatin-14 and the N terminally extended somatostatin-28 (SS-28), both of which are derived from a common precursor molecule (Brazeau et al., 1973) . Recently, a somatostatin-like peptide, cortistatin, with a high degree of homology but a more restricted distribution, has been isolated (de Lecea et al., 1996 (de Lecea et al., , 1997 . In the CNS, somatostatin acts as neurotransmitter and neuromodulator to regulate neuronal firing in a predominantly inhibitory manner and plays a role in the modulation of complex behaviors, such as motor activity and cognition (for review, see Gillies, 1997) .
The physiological effects of somatostatin are mediated through a family of seven transmembrane-spanning G-protein-coupled receptors (for review, see Bell and Reisine, 1993; Hoyer et al., 1995) . Five genes encoding distinct somatostatin receptor subtypes, termed sst 1 -sst 5 , have so far been cloned in humans and other species (Bruno et al., 1992; Kluxen et al., 1992; Meyerhof et al., 1992; O'Carroll et al., 1992; Vanetti et al., 1992 Vanetti et al., , 1993 Yamada et al., 1992; Yasuda et al., 1992; Rohrer et al., 1993) . Several different radioligands have been used to investigate the overall distribution of somatostatin binding sites in mammalian brain; however, none of the somatostatin receptor ligands used in these studies was sufficiently selective to allow definitive discrimination between the various receptor subtypes (Uhl et al., 1985; Martin et al., 1991; Holloway et al., 1996) . Elucidation of the cellular and subcellular localization of the various somatostatin receptor subtypes would provide important insights into somatostatinergic transmission in the CNS. So far, only the somatostatin receptor subtypes sst 1 , sst 2A , sst 2B , and sst 3 have been localized by immunocytochemistry in mouse and rat brain (Dournaud et al., 1996 Schindler et al., 1997 Schindler et al., , 1999 Helboe et al., 1998 Helboe et al., , 1999 Händel et al., 1999; Schulz et al., 1998b,c) .
The somatostatin receptor sst 4 binds SS-14 and SS-28 with high affinity and exhibits virtually no affinity for the synthetic somatostatin analogs seglitide and octreotide (Rohrer et al., 1993) . When stably expressed in Chinese hamster ovary or human embryonic kidney 293 (HEK 293) cells, sst 4 mediates inhibition of forskolin-stimulated cAMP formation and a prolonged activation of mitogen-activated protein kinase (Rohrer et al., 1993 , Bito et al., 1994 , Sellers, 1999 . In the CNS, sst 4 mRNA is highly expressed in the cerebral cortex, hippocampus, amygdala, and hypothalamus (Bito et al., 1994; Harrington et al., 1995; Perez and Hoyer, 1995) . In the present study, we raised antisera against a synthetic peptide corresponding to the C-terminal tail of sst 4 and used these antibodies to explore the distribution, targeting, and internalization of the sst 4 receptor protein in the brain of adult rats.
MATERIALS AND METHODS
Generation of anti-peptide antisera. Rabbit polyclonal antisera were generated against the C -terminal portion of sst4. The identity of the 23 amino acid sequence was CQQEPVQAEPGCKQV PF TK TTTF, which corresponds to residues 362-384 of the mouse sst 4 receptor. The peptide was custom synthesized by Gramsch Laboratories (Schwabhausen, Germany), purified by HPLC, and coupled via an N terminally added c ysteine and an SMCC (succinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate) linker to keyhole limpet hemocyanin. The conjugate (500 g /ml) was emulsified with an equal volume of Freund's complete adjuvant for the first and Freund's incomplete adjuvant for subsequent immunizations. T wo rabbits (6001 and 6002) were injected at 4 week intervals, and serum was obtained 2 weeks after immunizations beginning with the second injection.
Dot-blot anal ysis and immunoaffinit y purification. The specificity of the antisera, as well as possible cross-reactivity with other somatostatin receptor subtypes, was initially tested in dot-blot assays. Serial dilutions of the unconjugated peptides corresponding to the C-terminal sequences of sst 1 , sst 2A , sst 2B , sst 3 , sst 4 , and sst 5 were blotted onto nitrocellulose membranes. The identity of the peptides was as follows: ESGGVFRNGT-CASRISTL, which corresponds to residues 374 -391 of the mouse and rat sst 1 ; ETQRTLLNGDLQTSI, which corresponds to residues 355-369 of the human, mouse, and rat sst 2A ; ADNSKTGEEDTMAWV, which corresponds to residues 329 -343 of the rat sst 2B ; TAGDKASTLSHL, which corresponds to residues 417-428 of the mouse and rat sst 3 ; CQQEPVQA-EPGCKQVPFTKTTTF, which corresponds to residues 362-384 of the mouse sst 4 ; and QATLPTRSCEANGLMQTSRI, which corresponds to residues 344 -363 of the rat sst 5 receptor. Membranes were then incubated with the sst 4 antisera 6001 and 6002 at dilutions ranging from 1:1000 to 1:20,000 for 60 min at room temperature (RT). Blots were developed using peroxidase-conjugated secondary antibodies (1:5000) and enhanced chemiluminescence (Amersham Pharmacia Biotech, Braunschweig, Germany).
Immunoaffinity columns were constructed by cross-linking of the sst 4 C -terminal peptide CQQEPVQAEPGCKQV PF TK TTTF to iodoacetyl agarose columns, and purification of anti-sst 4 antiserum (6002) was performed using the SulfoLink K it (Pierce, Rockford, IL) as recommended by the manufacturer. Eluted fractions of purified IgG were pooled and rescreened using dot-blot analysis. In all subsequent experiments, affinity-purified anti-sst 4 antibodies were used.
Western blot anal ysis and degl ycosylation e xperiments. H EK 293 cells were stably transfected with rat sst 1 , rat sst 2A , T7-tagged rat sst 3 , T7-tagged rat sst 4 , or rat sst 5 receptors using the calcium phosphate precipitation method (Koch et al., 1998) . The T7 epitope tag was added at the N-terminal tail of sst 3 and sst 4 with a sequence encoding 11 amino acids of the T7 major capsid protein (M ASMTGGQQMG) using PCR (expression vectors for T7-tagged sst 3 and T7-tagged sst 4 were kindly provided by Dr. H.-J. Kreienkamp, (Institut f ür Z ellbiochemie und klinische Neurobiologie, Universität Hamburg, Hamburg, Germany) (Roth et al., 1997) . Approximately 1.5 ϫ 10 6 cells were transfected with 20 g of plasmid DNA. C ells were selected in the presence of 500 g /ml G418 (Life Technologies, Eggenstein, Germany). Membranes were prepared from stably transfected H EK 293 cells, as well as from several rat brain regions, including olfactory bulb, cortex, striatum, hippocampus, and cerebellum. Tissue was lysed in homogenization buffer (5 mM EDTA, 3 mM EGTA, 250 mM sucrose, and 10 mM Tris-HC l, pH 7.6, containing 1 mM phenylmethylsulfonylfluoride, 1 M pepstatin, 10 g /ml leupeptin, and 2 g /ml aprotinin). The homogenate was spun at 500 ϫ g for 5 min at 4°C to remove unbroken cells and nuclei. Membranes were then pelleted at 20,000 ϫ g for 30 min at 4°C and resuspended in lysis buffer (150 mM NaC l, 5 mM EDTA, 3 mM EGTA, and 20 mM H EPES, pH 7.4, containing 4 mg /ml dodecyl-␤-maltoside and proteinase inhibitors as above). The lysate was centrif uged at 20,000 ϫ g for 30 min at 4°C, and when indicated, glycoproteins were partially purified using wheat germ lectin agarose (WGA) (Vector Laboratories, Burlingame, CA). The supernatant was incubated with 100 l of WGA beads for 90 min at 4°C. Beads were washed five times, and adsorbed glycoproteins were eluted with SDS sample buffer (62.5 mM Tris-HC l, pH 6.8, 2% SDS, 20% glycerol, 200 mM DL-dithiotreitol, and 0.005% bromphenol blue) for 20 min at 60°C. Deglycosylation experiments were performed using peptide N-glycosidase F (PNGase F) according to the manufacturer's protocol (New England Biolabs, Beverly, M A). Either crude membrane proteins (100 g / lane) or WGA extracts purified from 500 g membrane proteins were subjected to 8% SDS-PAGE and immunoblotted onto nitrocellulose. Blots were incubated with affinity-purified anti-sst 4 (1 g /ml) or mouse monoclonal anti-T7 tag antibody (1:5000; Novagen, Madison, W I) overnight at 4°C and then developed using peroxidase-conjugated secondary antibodies and enhanced chemiluminescence. For adsorption controls, anti-sst 4 antibody was preincubated with 10 g /ml of its cognate peptide for 2 hr at RT.
Immunoc ytochemistr y. Wild-type H EK 293 cells or H EK 293 cells stably transfected with T7-tagged sst 3 or T7-tagged sst 4 receptors were grown on coverslips overnight. Primary dissociated cultures of rat hippocampus and cortex were prepared from embryonic day 19 fetuses and grown on coverslips for 1-2 weeks as described previously (Papa et al., 1995) . For internalization studies, cells were treated with 100 nM SS-14 for 10, 30, 45, or 60 min and fixed with 4% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate buffer, pH 7.4, for 1 hr at RT. Coverslips were washed several times in TPBS (10 mM Tris-HC l, 10 mM phosphate buffer, 137 mM NaC l, and 0.05% thimerosal, pH 7.4) and preincubated with TPBS containing 0.3% Triton X-100 and 3% normal goat serum (NGS) for 1 hr at RT. Primary neuronal cultures were then incubated with either affinity-purified anti-sst 4 (1 g /ml) or anti-sst 2A (1 g /ml). H EK 293 cells were incubated with a mixture of affinity-purified anti-sst 4 (1 g /ml) and mouse monoclonal anti-T7 antibodies (1:5000) in TPBS containing 0.3% Triton X-100 and 1% NGS overnight at 4°C. For adsorption controls, primary antibodies were preincubated with homologous peptides (10 g /ml) for 2 hr at RT. For single immunofluorescence, bound primary antibodies were detected with biotinylated antirabbit IgG antibodies (Vector Laboratories), followed by cyanine 3.18 (C y3)-conjugated streptavidin (Amersham Pharmacia Biotech). For double immunofluorescence labeling, bound primary antibodies were detected with biotinylated anti-rabbit IgG antibodies, followed by a mixture of cyanine 2.18 (C y2)-conjugated streptavidin and cyanine 5.18 (C y5)-conjugated anti-mouse antibodies (Jackson ImmunoResearch, West Grove, PA). C ells were then dehydrated in graded alcohols, cleared in xylol, and permanently mounted in DPX (Fluka, Neu-Ulm, Germany).
For light microscopy, male Wistar rats (n ϭ 8, 200 -230 gm; Tierzucht Schönwalde, Germany) were deeply anesthetized with chloral hydrate and transcardially perf used with T yrode's solution, followed by Z amboni's fixative containing 4% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate buffer, pH 7.4. In a separate set of experiments, rats received an intracerebroventricular injection of 1 g of SS-14 either 30 Figure 1 . Immunodot-blot analysis of the specificity of the anti-sst 4 antiserum. Serial dilutions (0 -2000 ng) of the peptides corresponding to the C-terminal regions of sst 1 , sst 2A , sst 2B , sst 3 , sst 4 , and sst 5 were blotted onto a nitrocellulose membrane and incubated with affinity-purified antisst 4 antibody (6002) at a concentration of 1 g/ml. The blot was subsequently incubated with peroxidase-conjugated secondary antibodies and developed using enhanced chemiluminescence.
(n ϭ 3) or 60 (n ϭ 3) min before vascular perf usion. Control animals received an equal volume of vehicle injection (n ϭ 6). Brains and spinal cords were rapidly dissected and post-fixed in the same fixative for 2 hr at RT. For all animal procedures, ethical approval was sought before the experiments according to the requirements of the German National Act on the Use of E xperimental Animals. Tissue was cryoprotected by immersion in 30% sucrose for 48 hr at 4°C before sectioning using a freezing microtome. Free-floating sections (30 -40 m) were washed in TPBS, placed in 50% ethanol for 30 min to block endogenous peroxidase activity, and incubated in 3% NGS in TPBS with 0.3% Triton X-100 for 1 hr. Tissue sections were then incubated with affinity-purified anti-sst 4 (1 g /ml in TPBS containing 0.3% Triton X-100 and 1% NGS) for 48 -72 hr at RT. Staining of primary antibody was detected using the biotin amplification procedure as described previously (Schulz et al., 1998b) . Briefly, tissue sections were transferred to biotinylated goat anti-rabbit IgG (1:1000 in TPBS containing 0.3% Triton X-100 and 1% NGS; Vector Laboratories) for 2 hr and incubated with avidin-biotinylated peroxidase complex (ABC) solution for 1 hr. Bound peroxidase was reacted with biotinylated-tyramine solution for 20 min, which was then visualized with streptavidin-C y3 for single immunofluorescence.
For double labeling of the sst 4 receptor with somatostatin, glial, or neuronal marker proteins, the anti-sst 4 antibody (2.5 g /ml) was coincubated for 48 -72 hr at RT with the following mouse monoclonal antibodies: anti-somatostatin (clone K121, 1:50; Biomeda, Foster C ity, CA), anti-microtubule-associated protein 2 (M AP-2) (1:2000; Sternberger Monoclonals, Baltimore, MD), anti-neurofilament (1:2000; SM I-312; Sternberger Monoclonals), or anti-glial fibrillary acidic protein (GFAP) (1:2000; Boehringer Mannheim, Mannheim, Germany). Binding of primary antibodies was detected with biotinylated anti-rabbit IgG antibodies (Vector Laboratories), followed by a mixture of C y2-conjugated streptavidin (Amersham Pharmacia Biotech) and C y5-conjugated anti-mouse IgG antibodies (Jackson ImmunoResearch). Double labeling of the sst 4 receptor with other somatostatin receptor subtypes required staining of the sections with two different primary antibodies raised in the same host species. Thus, tissue sections were first incubated with very low concentrations of anti-sst 2A (6291; 1:20,000), anti-sst 2B (5574; 1:40,000), or anti-sst 3 (7986; 1:30,000) antibodies, all of which have been raised and extensively characterized in our laboratory (Schulz et al., 1998a,b,c; Händel et al., 1999) . Staining of these antibodies was then detected using the biotin amplification procedure as described above. Sections were washed and incubated with affinity-purified anti-sst 4 antibody at a concentration of 2.5 g /ml overnight, followed by a final incubation with a mixture of C y2-conjugated streptavidin (Amersham Pharmacia Biotech) and C y5-conjugated anti-rabbit IgG antibodies (Jackson ImmunoResearch). Sections were mounted onto chrome alum gelatin-subbed glass slides and dehydrated in graded alcohols, cleared in xylol, and coverslipped with DPX. For immunocytochemical controls, the primary antibody was omitted, replaced by preimmune sera, or adsorbed with several concentrations ranging from 1 to 10 g /ml homologous or heterologous peptides for 2 hr at RT. Specimens were examined using a Leica (Heidelberg, Germany) TC S-N T laser scanning confocal microscope equipped with a krypton -argon laser. C y2 was imaged with 488 nm excitation and 500 -560 bandpass emission filter, C y3 with 568 nm excitation and 570 -630 nm bandpass emission filters, and C y5 with 647 nm excitation and 665 nm long-pass emission filters.
For electron microscopy, male Wistar rats (200 -230 gm) were anesthetized as above and perf usion-fixed (4% paraformaldehyde, 0.2% picric acid, and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4). The brains were post-fixed in 4% paraformaldehyde for 2 hr at RT. Blocks of brain tissue were washed for 2 hr in 0.1 M phosphate buffer, immersed in 10% sucrose for 1 hr, and then placed in 20% sucrose overnight at 4°C. Subsequently, tissue was snap frozen in liquid nitrogen and thawed in 0.1 M phosphate buffer. Seventy micrometer vibratome sections were collected, washed in TPBS, and transferred into 50% ethanol for 30 min. After 1 hr blocking in TPBS containing 3% NGS, tissue sections were incubated with anti-sst 4 antibody (1-2.5 g /ml in TPBS containing 1% NGS) for 72 hr. Sections were subsequently transferred to biotinylated anti-rabbit IgG antibodies and ABC solution. All incubations were performed at RT and without Triton X-100. Immunolabeling was visualized with DAB-glucose oxidase for 10 -30 min. Sections were post-fixed with 1% osmium tetroxide, en bloc contrasted with 1% uranyl acetate, dehydrated in a series of graded alcohols, and flatembedded in Durcupan. Ultrathin sections (40 -50 nm) were cut with a diamond knife using an ultracut MT 7000 (RMC, T uscon, AZ). Sections were collected onto copper mesh grids and examined with a Z eiss (Oberkochen, Germany) 900 electron microscope.
Cortical percussion trauma. Unilateral contusion was made to the cortex essentially as described by Bernert and T urski (1996) . Briefly, the contusion device for the rat brain injury consisted of a 40 cm longstainless steel tube. The device was kept perpendicular to the surface of the scull and guided a falling weight onto the foot plate resting on the surface of the dura. A force of 380 gm /cm 2 produced by a 20 gm weight was selected to produce brain contusion. Adult male Wistar rats were anesthetized with tribromoethanol (260 mg / kg, i.p.; Aldrich, Deisenhofen, Germany). A craniotomy was performed, and the center of the foot plate was stereotaxically positioned 1.5 mm posterior and 2.5 mm lateral to the bregma. Unilateral contusion was made to the cortex. Animals were killed by vascular perf usion after 8 (n ϭ 6) or 24 (n ϭ 6) hr as described above. Sham controls (n ϭ 6) had identical anesthesia and surgery without impact.
RESULTS

Characterization of antisera
Antisera were raised in rabbits against a synthetic peptide corresponding to residues 362-384 of the C terminus of sst 4 . Specificity of the antisera was initially monitored using immunodot-blot analysis. After four boost injections, both rabbit antisera (6001 and 6002) developed a titer against their immunizing peptide. When several dilutions of these antisera were tested, the anti-sst 4 antiserum 6002 detected quantities as low as 50 ng of its cognate peptide but not the peptides corresponding to other somatostatin receptor subtypes at a dilution of 1:20,000. Thus, the sst 4 antiserum 6002 was subjected to immunoaffinity purification, and the resulting IgG preparation was rescreened using immunodot-blot analysis (Fig. 1) .
The antiserum (6002) was further characterized using immunofluorescent staining of stably transfected HEK 293 cells. When wild-type HEK 293 cells or either sst 4 T7tag-or sst 3 T7tag-transfected cells were stained with a mixture of the anti-sst 4 antibody (6002) and the mouse monoclonal anti-T7 tag antibody and processed for double immunofluorescence, the anti-sst 4 antiserum yielded prominent immunofluorescence localized at the level of the plasma membrane only in HEK 293 cells bearing the sst 4 receptor (Fig. 2 A, C,G) . This staining pattern was completely blocked by preincubation of the antiserum with homologous peptide (Fig. 2 E) . In contrast, the anti-T7 antibody yielded prominent immunofluorescence localized at the level of the plasma membrane in HEK 293 cells transfected with either sst 4 T7tag or sst 3 T7tag but not in wild-type cells (Fig. 2 B, D,H ). This staining was not affected by preincubation with the sst 4 homologous peptide (Fig. 2 F) . In addition, the anti-sst 4 antiserum 6002 did not stain HEK 293 cells stably expressing the sst 1 , sst 2A , sst 3 , or sst 5 receptors (data not shown).
The specificity of the antibody was then tested by Western blotting analysis. When membrane preparations from stably (6002) at a concentration of 1 g/ml. B, Crude membrane preparations, WGA-purified preparations, or PNGase F-treated WGA extracts prepared from striatum and cortex were separated on an 8% SDS polyacrylamide gel and blotted onto nitrocellulose. Membranes were then incubated with affinity-purified anti-sst 4 antibodies (6002) at a concentration of 1 g/ ml. C, WGA extracts prepared from the olfactory bulb, cortex, striatum, hippocampus, and cerebellum were separated on an 8% SDS polyacrylamide gel and blotted onto nitrocellulose. Membranes were then incubated with affinity-purified anti-sst 4 antibodies (6002) at a concentration of 1 g/ml in either the absence (left panel ) or presence (right panel ) of the peptide antigen (10 g/ml). Blots were developed using enhanced chemiluminescence. Ordinate, Migration of protein molecular weight markers (M r ϫ 10
Ϫ3
).
transfected HEK 293 cells were analyzed, and the anti-sst 4 antibody 6002 detected a broad band migrating at 45-55 kDa only in membrane extracts from sst 4 T7tag-expressing cells but not in extracts from HEK 293 cells expressing other somatostatin receptor subtypes (Fig. 3A) . The anti-T7 tag antibody detected a single band of identical molecular weight in sst 4 T7tag-transfected cells (data not shown). In contrast, Western blot analysis of striatal and cortical membranes revealed a major band migrating at 65-72 kDa and a smaller band with migration properties similar to that seen in sst 4 -expressing HEK 293 cells (Fig. 3B) . After partial purification of N-glycosylated proteins from rat brain membranes using WGA, only the 65-72 kDa band was detected (Fig. 3B ). When these WGA extracts were subjected to enzymatic deglycosylation using PNGase F, a sharp band of ϳ48 -50 kDa was detected (Fig. 3B) . These data are consistent with the majority of rat brain sst 4 receptors being heavily glycosylated with the sst 4 receptors heterologously expressed in HEK 293 cells being either nonglycosylated or only partially glycosylated. In addition, WGA extracts from selected brain regions were subjected to Western blot analysis (Fig. 3C, left panel ) , showing that immunoreactive (IR) sst 4 receptors are present in high levels in the striatum, olfactory bulb, and cerebral cortex and to a lesser extent in the hippocampus and cerebellum. These bands were no longer detected when the antiserum was preincubated with its cognate peptide (Fig. 3B, right panel ) . When brain sections of adult rats were immunocytochemically stained, the sst 4 antibody revealed a selective staining pattern with high levels of sst 4 -like immunoreactivity (Li) in many forebrain regions, including the olfactory bulb, cerebral cortex, hippocampus, striatum, and amygdala (Figs. 4, 5 ). This immunostain- . E, Rat brain sections from the hippocampal CA1 region were processed for immunoperoxidase detection of the anti-sst 4 antibody. Note that sst 4 -Li is enriched in the hippocampal formation with high levels found in the Ammon's horn and the hilar region of the dentate gyrus. sst 4 -Li was also distributed along neuronal processes in the nucleus accumbens, striatum, and amygdala. At the electron microscopic level, immunoperoxidase product was always postsynaptic, and some instances of immunolabeling at asymmetrical synapses were found in the hippocampal CA1 region ( E). ac, Anterior commissure; Acc, nucleus accumbens, BLA, basolateral amygdaloid nucleus; Ce, central amygdaloid nucleus, CPu, caudate-putamen; DG, dentate gyrus; LGP, lateral globus pallidus; SO, stratum oriens; SP, stratum pyramidale, SR, stratum radiatum. ing was completely abolished by preabsorption of the sst 4 antibody with homologous, but not with heterologous, peptides (10 g/ml) (Fig. 4 B, C) .
Somatostatin receptor 4-Li is prominent in rat forebrain
sst 4 -Li was abundant throughout the rat forebrain (Figs. 4, 5 ). In the main olfactory bulb, sst 4 -Li was most dense in the external plexiform layer but was also seen in the glomerular, mitral cell, and internal granular layers. sst 4 -Li was also present in other structures of the olfactory system, including the anterior olfactory nucleus, olfactory tubercle, and islands of calleja. Prominent sst 4 -Li was found throughout the layers (I-VI) of the neocortex in which it decorated neuronal somata and processes, including those of pyramidal cells in layers III and V (Fig. 4 A) . Although the majority of these large layer V pyramidal cells are presumably glutamatergic, sst 4 -Li was seen on parvalbumin-containing (presumably GABAergic) neurons in layer IV. In the hippocampal formation, sst 4 -Li was detected in the Ammon's horn with similar densities throughout CA1-CA3 and in the hilar region of the dentate gyrus (Fig. 5A-C) . In the Ammon's horn, sst 4 -Li was present on apical dendrites of pyramidal cells in the stratum radiatum and scattered interneurons. In general, staining of the primary dendrites of both cortical and hippocampal pyramidal cells appeared to be more dense then the staining of the somata of these neurons (Figs. 4 D, 5D ). sst 4 -Li was also seen on scattered fibers within the hilar region of dentate gyrus (Fig. 5C ). sst 4 -Li was distributed along neuronal processes in the striatum, nucleus accumbens, and globus pallidus, with the highest density in the globus pallidus (Fig. 5 F, G) . In the amygdala, sst 4 -immunoreactive fibers and somata were abundant in the cortical, central, and basolateral nuclei (Fig. 5H ). In addition, sst 4 -Li was moderately dense in distinct nuclei of the thalamus. Moderate to strong fiber labeling was seen in the habenula, as well as in the lateral hypothalamic area. sst 4 -Li was present on Purkinje cells within the cerebellar cortex. Scattered sst 4 -IR fibers were seen in the ventral areas of the medulla and spinal cord. In general, sst 4 -Li was most prominent in the forebrain, and the density of sst 4 -Li progressively decreased within the caudal brain regions.
To further elucidate the subcellular targeting of the sst 4 -immunoreactive elements, double-labeling experiments of sst 4 with neuronal and glial markers were performed. In virtually all brain regions examined, sst 4 -Li was colocalized with MAP-2 but not with neurofilament or GFAP, indicating that the sst 4 receptor protein is predominantly targeted to the somatodendritic domain of neurons (data not shown). To elucidate the subcellular sites for sst 4 functions more precisely, we used the immunoperoxidase method and electron microscopy. When large apical dendrites from cortical pyramidal cells of layer V were examined, much of the immunolabeling appeared to be intracellular and not confined to the neuronal plasma membrane (Fig. 4 D-F ) . We also examined cortical layer I in which sst 4 -immunopositve pyramidal cells of layers III and VI project into and ramify. In contrast to that seen in the deeper layer of the cortex, sst 4 -positve immunolabeling was frequently more densely distributed along neuronal plasma membranes. The neuronal profiles containing sst 4 -Li were dendrites and symmetrical synapses (Fig. 4G ). This suggests that the predominant intracellular localization of the immunoperoxidase reaction product in large pyramidal cell dendrites may originate from sst 4 receptors being transported to or from their targets. In addition, very similar results were obtained for the striatum and hippocampus in which sst 4 -Li was exclusively postsynaptic. However, it should be noted that, in the hippocampal formation, some instances of sst 4 -positive immunolabeling of asymmetrical presumably excitatory synapses were found (Fig. 5E) .
Spatial relationship of somatostatin receptor 4 to its ligand somatostatin
To explore the relationship between the sst 4 receptor and its ligand(s), we used double immunofluorescence using the affinitypurified rabbit anti-sst 4 antibody (6002) and the mouse monoclonal anti-SS-14 antibody (clone K121). Immunodot-blot analysis revealed that the K121 antibody, which was generated to SS-14, does not discriminate between somatostatin and cortistatin (data not shown). Immunofluorescent confocal microscopy of doublelabeled sections showed a high degree of overlap between sst 4 -Li and SS-14-Li in many brain regions, including the cerebral cortex, striatum, and nucleus accumbens. High-power magnification revealed that sst 4 -immunoreactive dendrites were often closely apposed by, but not cocontained within, SS-14-containing fibers and terminals (Fig. 6 A-F,J ) . One notable exception was the hilar region of the dentate gyrus in which immunoreactive sst 4 receptors appeared to decorate processes of SS-14-positive interneurons. The fusiform cell bodies and very proximal portion of dendrites of these interneurons were intensely labeled for somatostatin immunoreactivity, whereas sst 4 -Li was localized to the adjacent more distal portions of these dendrites and their ramifications within the hilus (Fig. 6 I, K ) .
Spatial relationship of somatostatin receptor 4 to other somatostatin receptor subtypes
Finally, we examined the spatial relationships between sst 4 and the sst 2A , sst 2B , and sst 3 receptors, all of which are abundant in the same forebrain regions. As shown in Figure 7A -C, sst 2A -Li was prominent on fibers in the stratum oriens and radiatum of the hippocampal CA1. Although sst 4 -Li appeared to be in a similar position, no colocalization was observed between these two receptors (Fig. 7J ) . In contrast, a high degree of colocalization was seen between sst 4 -Li and sst 2B -Li in layer V cortical pyramidal cells (Fig. 7D-F ) . Interestingly, these two receptors differ in their subcellular targeting. Whereas sst 2B -Li was distributed in a patchlike manner at the plasma membranes of the soma and proximal dendrites, sst 4 -Li was most dense at the distal portion of the apical dendrites of these neurons (Fig. 7K ) . The sst 3 receptor is also abundant in the cerebral cortex. Whereas sst 3 -Li is selectively targeted to neuronal cilia, sst 4 -Li is most prominent in the dendritic domain of a subpopulation of cortical neurons. Nevertheless, a colocalization of these two receptors was not evident (Fig.  7G-I ).
The sst 4 receptor does not undergo agonist-promoted internalization in vivo
The sst 4 receptor is unique among somatostatin receptors in that it appears to be resistant against agonist-induced internalization when expressed in HEK 293 cells (Kreienkamp et al., 1998) . Because heterologous expression of sst 4 results in a receptor protein that is either not or incompletely glycosylated (Fig. 2) , it is important to determine agonist-induced endocytosis of the native receptor. When SS-14 was administered intracerebroventricularly and the subcellular distributions of the sst 4 and sst 2A receptors were monitored immunocytochemically, we found that the sst 2A receptor redistributed rapidly from the plasma membrane into vesicle-like structures in the cytosol (Fig. 8 A-D) . However, such a redistribution was not seen for the sst 4 receptor (Fig. 8 E-H ) .
In primary neuronal cultures native sst 4 and sst 2A receptors were readily detectable by immunofluorescence using somatostatin receptor subtype-specific antibodies. When these cultures were exposed to SS-14, the membrane-bound sst 2A receptors were progressively lost. After 45 min, nearly all sst 2A receptors redistributed from the plasma membrane into the cytosol (Fig. 9, top  panel ) . In contrast, such a loss of membrane-bound receptor with a concomitant accumulation of receptors in the cytosol was not E-H) antibodies. Micrographs shown in A and B were taken from the lateral septum, C and D were taken from the central gray, E and F were taken from the cortex, and G and H were taken from the hilar region of the dentate gyrus. Note that sst 2A rapidly redistributes from the plasma membrane into vesicle-like structures within the cytosol. In contrast, sst 4 appears to be resistant against short-term downregulation via receptor internalization. Scale bar: A-H, 25 m.
seen for the sst 4 receptor (Fig. 9, bottom panel ) . Very similar results were obtained in the presence of monensin, an inhibitor of endosomal acidification, which blocks receptor recycling (data not shown).
Dynamic changes of sst 4 -Li after percussion trauma of the cortex
Finally, we monitored time-dependent changes in sst 4 -Li in an animal model of neurotrauma. As shown in Figure 10 , 8 and 24 hr after traumatic injury, the immunoreactive sst 4 receptors progressively declined on the ipsilateral, but not on the contralateral, side of damage. This decline of neuronal sst 4 receptors coincided was an induction of sst 4 receptors in non-neuronal cells, as evidenced by their lack of colocalization with MAP-2. These cells exhibited a glial-like morphology and were present at 24 hr after neurotrauma at the sites of damage. The staining of these glial-like cells also appears to represent sst 4 -Li because it was completely neutralized by preincubation of the antibody with its immunizing peptide (data not shown).
DISCUSSION
In the present study, we have raised anti-peptide antisera against the C-terminal tail of the sst 4 receptor. Several lines of evidence suggest that these antibodies react specifically with their targeted receptor. First, in immunodot-blot assays, the anti-sst 4 antisera specifically detected their cognate peptide but not the peptides corresponding to the C-terminal region of other somatostatin receptor subtypes. Second, immunocytochemical staining of transfected HEK 293 cells revealed that the anti-sst 4 antisera selectively stained cells expressing the appropriate receptor but did not stain wild-type cells or cells transfected with other somatostatin receptors. In fact, the staining pattern of the anti-sst 4 antibody, which detects the C terminus of the sst 4 receptor, was virtually identical to that seen with anti-T7 tag antibody, which detects the N-terminal added epitope tag, suggesting that both antibodies recognized the same receptor. Third, on Western blots, the affinity-purified antibody detected a band that migrated at ϳ70 kDa before and ϳ50 kDa after enzymatic deglycosylation in rat brain. This staining was neutralized by preincubation of the antibody with its cognate peptide. In stably transfected HEK 293 cells, only a single band of ϳ50 kDa was detected by both the anti-sst 4 antibody (6002) and the anti-T7 tag antibody. These data suggest that the sst 4 receptor heterologously expressed in HEK 293 cells, as well as in other expression systems, may be either nonglycosylated or only partially glycosylated (Helboe et al., 1997) . In contrast, the native receptor expressed in rat brain appears to be heavily glycosylated. Fourth, the antibody revealed a unique staining pattern in brain tissue sections with prominent immunofluorescent in many forebrain regions. This immunostaining was completely abolished after preincubation of the antibody with the peptide (10 g/ml) used to immunize the rabbits. Moreover, the regional pattern of sst 4 -Li was largely consistent with the distribution of sst 4 mRNA reported by earlier in situ hybridization studies (Wulfsen et al., 1993; Bito et al., 1994; Harrington et al., 1995; Perez and Hoyer, 1995) . Finally, the C-terminal peptide is likely to have served as sst 4 -specific immunogen because this peptide was found to have amino acid identities no greater than 34% to other peptide sequences when aligned to current entries in the National Center for Biotechnical Information databases using BLAST 2.0.
Previous autoradiographic binding studies could not unequivocally identify the cellular location of the various somatostatin receptor subtypes in mammalian brain. High densities of binding sites were found in the olfactory bulb, cerebral cortex, dentate gyrus, CA1-CA3 subfields of the hippocampus, lateral septum, striatum, piriform cortex, and amygdala, a regional pattern that corresponds well with the distribution of sst 4 -Li. The development of sst 4 receptor-specific antibodies provides a level of cellular resolution that allowed us to define the subcellular localization of the sst 4 receptor protein. In the CNS of adult rats, sst 4 -Li was found on neuronal somata and dendrites. Somatodendritic targeting of the sst 4 receptor was confirmed by its frequent colocalization with dendritic, but not axonal or glial, markers. Moreover, at the electron microscopic level, sst 4 -Li was exclusively confined to dendrites, symmetrical, and, in some instances, asymmetrical synapses, suggesting that the sst 4 receptor may be poised to mediate both inhibitory and excitatory postsynaptic responses of somatostatin.
This conclusion is supported by our finding that sst 4 -Li and SS-14-Li show complementary distributions in many brain regions. Double-labeled immunofluorescent confocal microscopy revealed that sst 4 -immunoreactive dendrites were often closely apposed by, but not cocontained within, SS-14-containing fibers and terminals, suggesting that SS-14 may be indeed a physiological relevant ligand for the sst 4 receptor. A different receptorligand relationship, however, was revealed in the hilar region of the dentate gyrus in which sst 4 -Li decorated processes of SS-14-immunoreactive interneurons. These neurons have been described previously as HIPP cells (hilar interneurons projecting to the perforant path), with their dendritic arborizations confined to the hilus and axons traveling to the outer third of the dentate gyrus molecular layer (Hökfelt et al., 1974; Johannson et al., 1984; Esclapez and Houser, 1995; Freund and Buzsaki, 1996) . It is very tempting to speculate that sst 4 may function as an autoreceptor on these neurons. However, it is believed that SS-14 is mainly released from the axon terminals of these neurons and would thus have to diffuse over considerable long distances before it may activate the dendritic sst 4 receptor. To what extent SS-14 may be released from the dendrites of these interneurons is uncertain.
An interesting spatial relationship was also observed between sst 4 and sst 2B . Although both appear to be expressed by the same cortical pyramidal cells, sst 4 and sst 2B are being targeted to different postsynaptic sites. Whereas sst 2B -Li was distributed in a patch-like manner along the soma and proximal dendrites, sst 4 -Li was most dense at the distal portion of the apical dendrites of these neurons (Schulz et al., 1998c; Schindler et al., 1999) . Moreover, sst 4 and sst 3 mRNA have been reported to be coexpressed in cortical pyramidal cells (Perez and Hoyer, 1995) . We have shown previously that the sst 3 receptor is selectively targeted to neuronal cilia (Händel et al., 1999) . No more then one cilium originates from one neuronal cell body and extends into an intercellular pocket.
We have compared the agonist-induced internalization of the sst 4 receptor with the sst 2A receptor in two different in vivo models. Whereas the native sst 2A receptor was subject to rapid agonist-induced endocytosis, the native sst 4 receptor appeared to be resistant to short-term downregulation via receptor internalization. Previous mutagenesis experiments have demonstrated that the C-terminal tail of the sst 4 receptor may contain a negative regulatory motif for receptor internalization (Kreienkamp et al., 1998) . In fact, the rat sst 4 receptor can be made sensitive to agonist-induced internalization by mutation of a single threonine (T331). Thus, the different ligand-receptor internalization profiles observed for two major postsynaptic somatostatin receptors may hold important clues for short-and long-term desensitization of somatostatin-mediated signals.
Somatostatin has been implicated in the modulation of complex behaviors, such as motor activity and memory formation (Matsuoka et al., 1994) . In addition, levels of somatostatin are altered in several human brain dysfunctions, such as senile dementia of the Alzheimer type (Davies et al., 1980; Grouselle et al., 1998) and temporal lobe epilepsy (Robbins et al., 1991) . Both inhibitory and excitatory effects have been reported for somatostatin on hippocampal and cortical neurons (Dodd and Kelly, 1978; Pittman and Siggins, 1981; Delfs and Dichter, 1983; Moore et al., 1988) . Finally, electrophysiological studies have described postsynaptic and presynaptic actions of somatostatin (Boehm and Betz, 1997; Siggins, 1997, 1999) . Thus, the sst 4 receptor is well positioned to mediate postsynaptic somatostatin effects in these brain regions. However, delineation of the precise contribution of each of the somatostatin receptors to the modulation of complex behaviors would require subtype-selective agonists, which only recently have become available (Rohrer et al., 1998) .
In addition, we show that sst 4 is strictly neuronal. However, we also show that, 24 hr after traumatic injury, the immunoreactive sst 4 receptors were also present on non-neuronal cells. These cells were selectively seen at primary and secondary sites of damage and, thus, may play a role in the neuronal degeneration - regeneration process. Consequently, expression of sst 4 on these cells may offer the potential to modulate post-traumatic structural changes in the brain using sst 4 -selective ligands.
In conclusion, the present study provides the first description of the distribution of immunoreactive sst 4 receptor proteins in mammalian brain. We show that sst 4 is strictly somatodendritic and most likely functions in a postsynaptic manner. Unlike sst 2A -mediated responses, the sst 4 -mediated effects are not subject to short-term downregulation by receptor internalization. Finally, non-neuronal sst 4 receptors may have a previously unappreciated function during degeneration-regeneration processes.
